- Home
- WWR vs ZTEK Comparison
WWR vs ZTEK Comparison
Compare WWR & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.70
HOLD
Current Price
$0.49
Company Overview
Basic Information| Metric | WWR | ZTEK |
|---|---|---|
| Founded | 1977 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Metal Mining | Major Chemicals |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.7M | 68.8M |
| IPO Year | 2006 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WWR | ZTEK |
|---|---|---|
| Price | $0.70 | $0.49 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.92 | N/A |
| AVG Volume (30 Days) | ★ 841.0K | 90.9K |
| Earning Date | 05-13-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.46 |
| 52 Week High | $3.75 | $1.84 |
Technical Indicators
Market Signals| Indicator | WWR | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 37.54 |
| Support Level | $0.66 | $0.46 |
| Resistance Level | $0.83 | $0.57 |
| Average True Range (ATR) | 0.04 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 77.42 | 29.24 |
Price Performance
Historical Comparison WWR
ZTEK
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.